SEVENRICH CAPITAL Announces Group Participation of AHS Japan Corporation, Provider of the "Starband®" Cranial Remolding Helmet (World's No. 1 Market Share Product*1)
SEVENRICH CAPITAL to Group AHS Japan, a provider of cranial remolding helmets, and commence management support.
📋 Article Processing Timeline
- 📰 Published: March 30, 2026 at 20:00
- 🔍 Collected: March 30, 2026 at 22:56 (2h 56m after Published)
- 🤖 AI Analyzed: April 16, 2026 at 07:29 (392h 33m after Collected)
SEVENRICH CAPITAL Co., Ltd. (Headquarters: Shibuya-ku, Tokyo; Representative Director: Kenzo Hattori; hereinafter referred to as SEVENRICH CAPITAL), which supports corporate growth through business succession and M&A, announces that AHS Japan Corporation (Headquarters: Chuo-ku, Osaka; Representative Director: Hidetoshi Koga; hereinafter referred to as AHS Japan Corporation), the domestic provider of the world's No. 1 market share*1 cranial remolding helmet "Starband® (Starband)", has joined the SEVENRICH GROUP.
About AHS Japan Corporation's Participation in the SEVENRICH GROUP
AHS Japan Corporation provides the cranial remolding helmet "Starband®", developed by Orthomerica Inc. in the United States, within Japan, and is committed to providing treatment opportunities for cranial deformities in infants and young children.
This active-type product is a fully custom-made cranial remolding helmet designed to fit the unique head shape of each individual. It has been adopted in over 37 countries worldwide*2 and used by over 600,000 infants and young children cumulatively*3, making it the world's No. 1 market share*1 product.
Since its introduction in Japan in 2007, it has been provided for over 18 years, with a cumulative track record of over 14,000 users*4. Furthermore, in collaboration with over 45 university hospitals and core medical institutions nationwide*5, a provision system has been established through referrals from medical institutions.
SEVENRICH CAPITAL evaluated the company's track record of collaboration with medical institutions, its achievements in the field of cranial remolding treatment, and its growth potential, leading to the decision for AHS Japan Corporation to join the SEVENRICH GROUP.
Business Growth Support by SEVENRICH CAPITAL
SEVENRICH CAPITAL supports companies in joining the SEVENRICH GROUP through business succession and M&A, and provides hands-on support for corporate growth after their participation.
We will support the sustainable growth of companies by leveraging back-office functions such as accounting and tax, as well as the group network.
With the participation of AHS Japan Corporation in the group, we will promote the development of the business operation system, focusing on strengthening marketing and sales strategies, to further drive the company's business growth.
We will enhance information dissemination regarding the features and value of Starband®, such as its full custom-made design tailored to each individual's head shape and growth, and its abundant clinical results, as well as enrich information provision for parents.
In addition, we will advance the sophistication of sales activities to pediatricians, university hospitals, postpartum care facilities, etc., aiming to establish a system where treatment information reaches the appropriate parties at the right time.
This will lead to increased awareness of cranial remolding treatment and the creation of treatment opportunities.
FAQ
What is Starband®?
Starband® is a custom-made cranial remolding helmet developed by Orthomerica Inc. in the United States. It is used to treat cranial deformities in infants and young children and holds the world's No. 1 market share in this field.
What is the significance of AHS Japan Corporation joining the SEVENRICH GROUP?
AHS Japan Corporation's participation signifies SEVENRICH CAPITAL's commitment to supporting the growth of AHS Japan. SEVENRICH CAPITAL will provide management support, including strengthening marketing and sales strategies, to further expand the business of Starband® in Japan.
What is SEVENRICH CAPITAL's role in supporting AHS Japan Corporation?
SEVENRICH CAPITAL will leverage its expertise in business succession and M&A, along with its group network and back-office functions (accounting, tax), to provide hands-on support. This includes enhancing marketing and sales, improving operational systems, and increasing information dissemination about Starband®.
What is the market position of Starband®?
Starband® is the world's No. 1 market share product for cranial remolding helmets, adopted in over 37 countries and used by over 600,000 infants and young children globally. In Japan, it has been provided for over 18 years with more than 14,000 users.
How will SEVENRICH CAPITAL help grow AHS Japan's business?
SEVENRICH CAPITAL plans to strengthen marketing and sales strategies, enhance information provision for parents, and improve sales activities targeting medical institutions. The goal is to increase awareness of cranial remolding treatment and create more treatment opportunities.